PTC Therapeutics (PTCT)
(Real Time Quote from BATS)
$25.22 USD
+0.01 (0.04%)
Updated Apr 25, 2024 01:28 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | *AMC4/25/24 |
---|---|
Current Quarter | -1.31 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | -182.76% |
ABR | 2.84 |
Earnings ESP
|
13.74% |
---|---|
Current Year | -5.94 |
Next Year | -5.34 |
EPS (TTM) | -6.54 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 160.27M | 149.92M | 606.57M | 616.01M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 187.30M | 173.00M | 675.80M | 747.97M |
Low Estimate | 119.10M | 118.50M | 469.70M | 332.80M |
Year ago Sales | 220.38M | 213.81M | 937.82M | 606.57M |
Year over Year Growth Est. | -27.28% | -29.88% | -35.32% | 1.56% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.31 | -1.40 | -5.94 | -5.34 |
# of Estimates | 7 | 7 | 9 | 8 |
Most Recent Consensus | -1.93 | -1.39 | -5.41 | -5.01 |
High Estimate | -0.87 | -0.77 | -3.65 | -1.98 |
Low Estimate | -1.93 | -1.95 | -8.45 | -9.16 |
Year ago EPS | -1.88 | -2.66 | -3.62 | -5.94 |
Year over Year Growth Est. | 30.32% | 47.37% | -64.09% | 10.11% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 3 | 2 | 4 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 3 | 5 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.31 | -1.40 | -5.94 | -5.34 |
7 Days Ago | -1.31 | -1.40 | -5.94 | -5.34 |
30 Days Ago | -1.31 | -1.40 | -5.95 | -5.36 |
60 Days Ago | -1.26 | -1.58 | -5.94 | -4.85 |
90 Days Ago | -1.16 | -1.63 | -5.55 | -4.26 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -1.40 | -6.29 | -7.10 |
Zacks Consensus Estimate | -1.31 | -1.40 | -5.94 | -5.34 |
Earnings ESP | 13.74% | 0.00% | -5.93% | -33.02% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -1.76 | -2.66 | -1.88 | NA |
Estimate | 0.29 | -0.85 | -1.58 | -1.64 | NA |
Difference | -0.53 | -0.91 | -1.08 | -0.24 | -0.69 |
Surprise | -182.76% | -107.06% | -68.35% | -14.63% | -93.20% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more